Monthly Archives: November 2009

77 Percent Transparency on FDA’s Advisory Committees

With great fanfare, the FDA launched a transparency initiative early this year.  The activities included the formation of a Transparency Task Force, the creation of a Transparency Blog, not one but two public meetings held on the subject of transparency, … Continue reading

Posted in Uncategorized | 3 Comments

Happy Thanksgiving

Stick a fork in me, I'm done! I'm taking the rest of the week off for the holiday.  In the meantime, I wish for each and every one of you a safe, tasty and pleasant Thanksgiving holiday in the states, … Continue reading

Posted in Miscellaney | 5 Comments

Priorities

In the wake of the FDA's Part 15 meeting on social media, all eyes are on the horizon to see what is to come.  FDA's Janet Woodcock said at the FDLI Conference this fall that the issue of social media, … Continue reading

Posted in Uncategorized | 1 Comment

What We Didn’t Hear at the FDA Part 15 Meeting on Social Media

Well, we heard a lot  week before last at the FDA's Part 15 Meeting on Social Media and Medical Product Promotion. For example, we heard consensus that medical product manufacturers probably shouldn't be held responsible for what unrelated third parties … Continue reading

Posted in FDA Policy, New and Social Media | 4 Comments

Weekly Roundup – 11-20-09

Ok, I'm two days late and a dollar short.  It was busy last week.  And then there is this thing called my job, which someone actually expects me to do, at least now and then.  But some interesting stuff went … Continue reading

Posted in Uncategorized | Comments Off